Bladder Cancer TNM Staging Primary Tumor (T) T3A
1 clinical trials · Condition
◉ Watch Bladder Cancer TNM Staging Primary Tumor (T) T3A
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer (NCT03518320) | Taris Biomedical LLC | 2019-01-02 |
Track Bladder Cancer TNM Staging Primary Tumor (T) T3A automatically
Every clearance here is in the API, with alerts when new ones post.